Mediaplanet's Blood Cancers & Disorders campaign launches nationally this Friday, September 25, within USA TODAY and online through Mediaplanet's Future of Personal Health digital content hub. The ...
Blood disorders known as myelodysplastic syndromes/neoplasms (MDS) are difficult to diagnose—and are commonly misdiagnosed—putting patients at increased risk for treatment mistakes and other ...
Verywell Health on MSN
Hematologist oncologists and what they do
Hematology oncology focuses on diagnosing and treating cancers of the blood, bone marrow, and lymphatic system. You might be ...
Dr. David Garcia is a board-certified hematologist and researcher at Fred Hutch, specializing in non-malignant hematology and thrombotic disorders. He leads research and contributes to international ...
AVAHO president hopes free event will prompt new hematology pathways The Association of Veterans Affairs Hematology/Oncology (AVAHO) will provide more than education during a special virtual session ...
Researchers have made a groundbreaking discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with ...
Please provide your email address to receive an email when new articles are posted on . Researchers at Children’s Hospital of Philadelphia and Perelman School of Medicine at University of Pennsylvania ...
BALTIMORE, July 15, 2025 (GLOBE NEWSWIRE) -- Auerbach Hematology and Oncology Associates PC, a trusted name in hematology and oncology care in Baltimore, Maryland, is proud to announce it has joined ...
Background: The US Department of Veterans Affairs (VA) National Oncology Program (NOP) has established a standard for veteran-focused cancer care across the Veterans Health Administration. This ...
Please provide your email address to receive an email when new articles are posted on . Pomalidomide provided durable control of nosebleeds, the hallmark symptom of hereditary hemorrhagic ...
The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson's drug to treat a rare blood disorder, the company said on Monday.
Welcome to the Hematology and Medical Oncology Fellowship Program. We prioritize cultivating a supportive and collaborative learning environment. Our training emphasizes research-based, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results